10.10.18
Burt’s Bees is sponsoring Dermveda’s first annual Integrative Dermatology Symposium (IDS), and event that aims to bring together experts from around the world practicing various types of dermatology (Western, Naturopathic, Ayurvedic, and Traditional Chinese Medicine) for a holistic look at the current dermatology landscape with a focus on improving patient experience. IDS is scheduled for Oct. 19-21 in Sacramento, CA.
At IDS, Burt’s Bees will present new data on its Sensitive Skin product line.Hemali Gunt, PhD, head of clinical and scientific affairs, Burt’s Bees, will present the posters, which will discuss its sensitive skin care regimen and its effect on skin barrier function, skin hydration and anti-inflammatory activity compared to a dermatologist-recommended synthetic skin regimen.
Burt's Bees' presentations will include:
• Nature-Based Sensitive Skin Regimen Improved Barrier Function and Maintained Skin Hydration in Patients with Clinically Diagnosed Sensitive Skin;
• Improved Outcomes Following a Nature-Based Sensitive Skin Regimen in Patients with Sensitive Skin Related to Rosacea or Atopic Dermatitis/Eczema; and
• Whole Formula Nature Based Sensitive Skin Product Demonstrate In Vitro Anti-Inflammatory Activity from Human Epidermal Keratinocytes.
At IDS, Burt’s Bees will present new data on its Sensitive Skin product line.Hemali Gunt, PhD, head of clinical and scientific affairs, Burt’s Bees, will present the posters, which will discuss its sensitive skin care regimen and its effect on skin barrier function, skin hydration and anti-inflammatory activity compared to a dermatologist-recommended synthetic skin regimen.
Burt's Bees' presentations will include:
• Nature-Based Sensitive Skin Regimen Improved Barrier Function and Maintained Skin Hydration in Patients with Clinically Diagnosed Sensitive Skin;
• Improved Outcomes Following a Nature-Based Sensitive Skin Regimen in Patients with Sensitive Skin Related to Rosacea or Atopic Dermatitis/Eczema; and
• Whole Formula Nature Based Sensitive Skin Product Demonstrate In Vitro Anti-Inflammatory Activity from Human Epidermal Keratinocytes.